Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Non-Current Assets: 2022-2025

Historic Non-Current Assets for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Sep 2025 value amounting to $7.0 million.

  • Orchestra BioMed Holdings' Non-Current Assets rose 4.03% to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.0 million, marking a year-over-year increase of 4.03%. This contributed to the annual value of $7.0 million for FY2024, which is 14.82% up from last year.
  • As of Q3 2025, Orchestra BioMed Holdings' Non-Current Assets stood at $7.0 million, which was up 1.38% from $6.9 million recorded in Q2 2025.
  • In the past 5 years, Orchestra BioMed Holdings' Non-Current Assets registered a high of $160.2 million during Q2 2022, and its lowest value of $5.9 million during Q2 2024.
  • In the last 3 years, Orchestra BioMed Holdings' Non-Current Assets had a median value of $6.4 million in 2023 and averaged $6.5 million.
  • As far as peak fluctuations go, Orchestra BioMed Holdings' Non-Current Assets slumped by 96.07% in 2023, and later climbed by 17.64% in 2025.
  • Orchestra BioMed Holdings' Non-Current Assets (Quarterly) stood at $10.9 million in 2022, then slumped by 43.96% to $6.1 million in 2023, then climbed by 14.82% to $7.0 million in 2024, then climbed by 4.03% to $7.0 million in 2025.
  • Its last three reported values are $7.0 million in Q3 2025, $6.9 million for Q2 2025, and $7.1 million during Q1 2025.